• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Market for Molecular Diagnostics Tests, 11th Edition

$6,000.00 – $12,000.00

Clear
SKU: 22-053 Categories: Diagnostics Market Research, Infectious Disease, Molecular & Nucleic Acid Testing, Oncology & Hematology Market Reports, Point-of-Care Diagnostics Tags: Molecular Blood Screening Diagnostics Market, Molecular Cancer Diagnostics Market, Molecular Diagnostics Market, Molecular Histology and Cytology Diagnostics Market, Molecular Infectious Disease Diagnostics Market, Molecular Inherited Diseases Diagnostics Market, Molecular Transplant Diagnostics Market Pages: 296
  • Description
  • Table of Contents
  • Latest reports

Description

Kalorama Information’s 11th Edition report of the clinical molecular testing industry provides marketing sizing and forecasts for in vitro diagnostics (IVDs) over a five-year period. In this report, our industry experts and top analysts assess the current positions of this complex market, which has an estimated value of more than $21 billion. This data publication has become an indispensable tool in clinical healthcare medicine and assesses the business opportunity, new product introductions, and rapid changes in several areas of this industry, including:

  • Infectious Disease Molecular Diagnostics (COVID-19, Hepatitis, HIV, Respiratory, STI, Others)
  • Cancer Molecular Diagnostic Markets (Blood-based and Tissue-based)
  • Genetic Molecular Diagnostic Markets (SNPs, Inherited, NIPT, Other)
  • Blood Banking Molecular Diagnostics Markets
  • Transplantation Molecular Diagnostic Markets
  • Regional Molecular Diagnostics Markets (North America, Europe, Asia, Global)

Molecular diagnostics proved their value during the COVID-19 pandemic, but the heavily competitive market in 2022 demonstrates that market leaders need to anticipate quick and rapid changes. Companies considered in this report include:

  • Abbott
  • ARUP
  • Asuragen
  • Becton, Dickinson &Co.
  • BGI
  • Biocartis
  • BioMérieux
  • Bio-Rad
  • CareDX
  • Cepheid
  • Credo
  • CTK
  • Eiken
  • Greiner Bio-One
  • Grifols
  • Hologic
  • Illumina
  • Leica Biosystems
  • Meridian Bioscience
  • Myriad
  • Perkin Elmer
  • Promega
  • Qiagen
  • QuantuMDX
  • QuidelOrtho
  • Roche Diagnostics
  • T2
  • Thermo Fisher
  • Vela Diagnostics

Get a needed jumpstart on market positioning for your business in 2023 and purchase your 11th edition copy today.

Table of Contents

Chapter One: Executive Summary

Size of Molecular Diagnostics Market

  • Figure 1-1: Molecular Diagnostics Market (w COVID-19 and w/out COVID-19, $B)

Growth Areas in Molecular Diagnostics

  • Figure 1-2: Non-COVID-19 Growth Applications by Revenue Growth %
  • Figure 1-3: COVID-19 Molecular Testing Market, 2020- Q2 2022 ($M)

Recent Developments

Emerging Trends

Monkeypox

Automation

Molecular Point of Care

  • Table 1-1: Market-Available Molecular POC Diagnostic Platforms

Next-Generation Sequencing

CRISPR

Other 2022 Developments in Molecular Diagnostics

 

Chapter Two: 2022 COVID-19 Molecular Diagnostic Market Analysis

Major IVD Players See Decline in COVID-19 Sales

  • Table 2-1: Selected COVID-19 Molecular Tests from Major Suppliers
  • Figure 2-1: Estimated COVID-19 Molecular Diagnostics Global Monthly Volume (# tests)
  • Figure 2-2: Estimated Monthly COVID-19 Molecular Diagnostic Test Volume, 2020- Q2 ’22 by Region ($M)
  • Table 2-2: COVID-19 Molecular Diagnostic Revenues by Region Estimated: North America, Europe, APAC, ROW, LATAM (#M)
  • Figure 2-3: COVID-19 Molecular Diagnostic Estimated Quarterly Rev. 2020- Q2’22 by Region
  • Figure 2-4: Estimated Molecular Diagnostic COVID-19 Revenue Shares, 2020-Q2’22 by Region

North America

  • Figure 2-5: USA – New Cases per Day
  • Figure 2-6: USA – Testing Volume per Day
  • Figure 2-7: Canada – New Cases per Day
  • Figure 2-8: Canada – Testing Volume per Day

Europe

  • Figure 2-9: Italy – New Cases per Day
  • Figure 2-10: Italy – Daily Testing Volume
  • Figure 2-11: Russia – New Cases per Day
  • Figure 2-12: Russia – Testing Volume per Day

APAC

  • Figure 2-13: India – New Cases per Day
  • Figure 2-14: India – Daily Testing Volume
  • Figure 2-15: Australia – New Cases per Day
  • Figure 2-16: Australia – Daily Testing Volume

Latin America

  • Figure 2-17: Colombia – New Cases per day
  • Figure 2-18: Colombia – Daily Testing Volume
  • Figure 2-19: Chile – New Cases per Day
  • Figure 2-20: Chile – Daily Testing Volume

Rest-of-World

  • Figure 2-21: Turkey – New Cases per Day
  • Figure 2-22: Turkey – Daily Testing Volume
  • Figure 2-23: South Africa – New Cases per Day
  • Figure 2-24: South Africa – Daily Testing Volume

COVID Testing Market Computation Methodology

Test Vendors

  • Table 2-3: Other PCR Tests Products on the Market

 

Chapter Three: Molecular Diagnostics Market

Brisk Recent Activity

Recent Product Introductions and Regulatory Approvals

  • Table 3-1: Recent Product Introductions
  • Table 3-2: Regulatory Approvals and Announcements

Market Size and Forecast by Segments

  • Table 3-3: Molecular Diagnostic Market, 2022 and 2027 by Segment, $M (HAI/Sepsis, Hepatitis, HIV, STIs, Respiratory, TB, Cancer Assays, Histology (ISH, FISH) Molecular HPV, NAT Blood Screening,  NIPT, Thrombophilia/SNPs, Pharmacogenomics, Inherited/ genetic, Transplantation, COVID-19)
  • Table 3-4: Molecular Diagnostics Market w/ and w/o COVID
  • Table 3-5: Molecular Diagnostic (non-COVID) Market, 2022 by Region ($M)
  • Figure 3-1: Molecular Diagnostics (non-COVID) Market by Region 2022 ($M)

Infectious Diseases

  • Table 3-6: Selected Molecular Hepatitis Tests

HIV Market and COVID-19 Impact

  • Table 3-7: Selected Molecular Test Products for HIV

NAT Blood Screening

COVID-19 Impact

Other Trends

Declining Blood Transfusions in Developed Markets

Molecular Histology and Cytology Diagnostics

HPV

Product Developments

Markets for Molecular Cancer Diagnostics

Liquid Biopsy

Molecular Transplant Diagnostics

  • Table 3-8: Selected Innovations in the Field of Molecular Transplant Diagnostics

Molecular Inherited Diseases Diagnostics

Thrombophilia and Coagulation Markers

Non-Invasive Prenatal Testing (NIPT)

Promising NIPT Studies

Inherited Disease Tests

Molecular Diagnostics Market Deals, Collaborations, Acquisitions

  • Table 3-9: Molecular Diagnostics Market Deals, Collaborations, Acquisitions

 

Chapter Four: Trends to Watch – Sequencing, CRISPR, Automation

Sequencing

NGS and Companion Diagnostics

  • Table 4-1: Selected Clinical NGS Platforms in the Market

Outlook For NGS in Molecular Diagnostics

  • Figure 4-1: Percent of the MDX Market Revenues by Test Technique 2022

Evolving Informatics Solutions in Clinical Sequencing

Sample Preparation and Quality Control

Lab Automation and Molecular Diagnostics

  • Table 4-2: Selected Automated Molecular Test Instrument Platforms

CRISPR and Molecular Diagnostics

CRISPR and COVID-19

  • Table 4-3: CRISPR Innovations

 

Chapter Five: Company Profiles

Abbott Diagnostics

Company Overview

Financial Review

  • Table 5-1: Abbott Diagnostics’ Recent Revenue History ($M), 2015-2021
  • Figure 5-1: Abbott Diagnostics’ Molecular Diagnostic Revenue History ($M), 2016- Q2 2022
  • Figure 5-2: Abbott Rapid Diagnostics Revenue

FDA approval of Alinity m STI assay

FDA approval of ALK Break Apart FISH Probe Kit

Alinity s System

WHO prequalification (PQ) approval of viral load test

Advanced Cell Diagnostics (Bio-Techne)

Agena Bioscience

Agendia BV

Agilent Technologies (incl. Dako)

Company Overview

Financial Review

  • Table 5-3: Agilent Technologies’ Recent Revenue History ($ millions)
  • Figure 5-3: Agilent Diagnostics and Genomics Revenues, 2016- Q3 2022 ($M)

Aidian Oy

Altona Diagnostics

Amoy Diagnostics

Applied Spectral Imaging

ARUP Laboratories

Asuragen Inc. (Bio-Techne)

Becton, Dickinson & Co. (BD)

Business Segments

BD Medical

BD Life Sciences

BD Interventional

Recent Acquisitions

TVA Medical, Inc.

  1. R. Bard, Inc.

CareFusion Corporation

Recent Divestitures

Advanced Bio-processing

Respiratory Solutions and Vyaire Medical

Leading Position in the Flow Cytometry Market

Revenue and Growth

  • Figure 5-4: BD Life Sciences Unit Quarterly Revenues, 2020- Q2’22 ($M)

Molecular Diagnostics Focus

Beijing Genomics Institute (BGI)

Sequencing Technologies

Berry Genomics

binx health

Bio-Rad Laboratories, Inc.

Key Comment

Recent Revenue History

Table 5-4: Bio-Rad Revenue History ($M)

Biocartis

Company Overview

Financial Review

  • Table 5-5: Biocartis’ Recent Revenue History ($ millions)

Products and Technologies

Biodesix

Biomeme, Inc

bioMérieux

  • Figure 5-6: bioMérieux’s Molecular Biology and Microbiology Segments, 2016-2022

Molecular

Bioneer

AccuPower COVID-19 Real-Time RT-PCR Kit

CareDx, Inc.

  • Figure 5-6: CareDx Revenue, 2017-2022

AlloMap Tests

AlloSure Tests

Products Offered by CareDx

Credo Bioscience

CTK Biotech

Danaher (Cepheid and Leica Biosystems)

Life Sciences Business

Diagnostics Business

Cepheid

Leica Biosystems

Danaher’s 2019 Performance and 2020 Expectations

  • Figure 5-7: Danaher Major Segment Revenues by Quarter, Q1 2018 – Q2 2022 ($M)

DiaSorin

Eiken Chemical

Exact Sciences Corp.

GenMark Diagnostics (Roche)

  • Figure 5-8: Gen Mark Revenues, Pre Acquisition

Genotypic Technology Pvt. Ltd.

Greiner Bio-One GmbH

Grifols, S. A

Molecular Immunohematology and Specialty Testing Products

NAT Blood Screening

Hologic, Inc.

  • Figure 5-9: Hologic Diagnostics Revenues, Calendar Q4 2017 – Q2 2022 ($M)
  • Table 5-6: Hologic’s Recent Revenue History ($ millions)

Illumina, Inc.

Company Overview

  • Table 5-7: Illumina’s Recent Revenue History ($ millions)
  • Figure 5-9: Illumina’s Recent Revenue History ($ millions)

Immucor, Inc.

Transfusion Diagnostics

Meridian Bioscience Inc

  • Figure 5-10: Meridian Bioscience Quarterly Revenues, Calendar Q1 2015 – Q2 2022 ($M)

Molbio Diagnostics Pvt. Ltd.

Myriad Genetics, Inc.

Company Overview

Financial Review

  • Table 5-8: Myriad Genetics’ Recent Revenue History ($ millions)

NanoString Technologies, Inc.

NeuroMoDX

Oxford Nanopore Technologies Ltd

PerkinElmer Inc.

Promega Corporation

Qiagen

Company Overview

Thermo Fisher Purchase

  • Table 5-9: QIAGEN’s Recent Revenue History ($ millions)

QuantuMDx Group

QuidelOrtho

Rheonix, Inc.

Products

Roche Diagnostics

Company Overview

Financial Review

  • Figure 5-11: Roche Quarterly Molecular Diagnostics Revenues, Q1 2016 – Q2 2022 ($M)
  • Table 5-10: Roche Diagnostics’ Recent Revenue History ($M)

Recent Regulatory and Product Developments

Cobas Liat System – POC

Acquisition of GenMark Diagnostics

Sysmex Agreement

Non-Exclusive 15-Year Collaboration With Illumina

Approval for cobas EZH2 Mutation Test

June 2020 – partnership with SpeeDX

Stratos Genomics

HPV

PLUS Cytoogy

ASPiRATION study

Cobas Zika test for blood screening

FDA approval of Babesia test

Release of NAVIFY Guidelines app

EBV and BKV Tests on the cobas 6800/8800 Systems

Expanded use of VENTANA PD-L1 (SP142) Assay in triple-negative breast cancer (TNBC)

FDA 510(k) clearance for cobas TV/MG test

Seegene

Sekisui Diagnostics LLC

Sherlock Biosciences

SOLVD Health (AutoGenomics)

Standard BioTools

T2 Biosystems

Thermo Fisher Scientific Inc.

Company Overview

  • Table 5-11: Thermo Fisher’s Recent Revenue History ($ millions)

Transplant Diagnostics

qPCR

Sequencing

Qiagen Acquisition Scrapped

Vela Diagnostics

Veracyte, Inc.

 

    In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028
    September 22, 2023
    The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition
    August 24, 2023
    30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)
    August 21, 2023
    At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023
    June 6, 2023

Related products

  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00
  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    The U.S. Market for Interventional Radiology Products

    $3,500.00 – $7,000.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Precision Cancer Therapeutics Market, 2022 The Market for Medical Devices, 12th Edition
Scroll to top